Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy

By Chin Sze-Piaw   Poey Alfred C.   Wong Chee-Yin   Chang Sau-Kong   Teh William   Mohr Teddric Jon   Cheong Soon-Keng  

Cytotherapy, Vol. 12, Iss. 1, 2010-01 ,pp. : 31-37

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up

By Deda H.   Inci Mc   Kurekci Ae   Kayıhan K.   Ozgun E.   Ustunsoy Ge   Kocabay S.  

Cytotherapy, Vol. 10, Iss. 6, 2008-10 ,pp. : 565-574

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up

By Deda H.   Inci Mc   Kurekci Ae   Sav A.   Kayıhan K.   Ozgun E.   Ustunsoy Ge   Kocabay S.  

Cytotherapy, Vol. 11, Iss. 1, 2009-02 ,pp. : 18-25

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains

By Barzilay Ran   Sadan Ofer   Melamed Eldad   Offen Daniel  

Cytotherapy, Vol. 11, Iss. 4, 2009-07 ,pp. : 435-442

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of human bone marrow-derived mesenchymal stromal cells: serum-reduced medium is better than conventional medium

By Montzka Katrin   Führmann Tobias   Wöltje Michael   Brook Gary A.  

Cytotherapy, Vol. 12, Iss. 5, 2010-09 ,pp. : 587-592

Ashgate Publishing Ltd

Access to resources Recommend Favorite